Support MS Research

Make a Donation

Sign Up to eNewsletter

Be the first to receive the latest news on MS Research.

Clinical trials in NSW

Showing 1 to 10 of 13

The direct benefit of neuropsychological assessment with feedback in multiple sclerosis

7th February, 2012

Type of MS: all

Read More

Efficacy and safety of Teriflunomide in patients with relapsing multiple sclerosis and treated with interferon-beta (TERACLES)

9th August, 2011

Type of MS: relapsing-remitting

Read More

Tolerability and safety and health outcomes in relapsing multiple sclerosis (MS) patients

9th August, 2011

Type of MS: relapsing-remitting

Read More

An examination of prospective memory in MS,employment difficulties, and early departure from work

9th August, 2011

Type of MS: all

Read More

A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis

9th August, 2011

Type of MS: relapsing-remitting

Read More

Australian MS Longitudinal Study

9th August, 2011

Type of MS: all

Read More

Study of SB-683699 compared to placebo in subjects with relapsing-remitting multiple sclerosis (MS)

9th August, 2011

Type of MS: relapsing-remitting

Read More

Efficacy and safety of Daclizumab high yield process versus Interferon β 1a in patients with relapsing-remitting multiple sclerosis

9th August, 2011

Type of MS: relapsing-remitting

Read More

Post marketing surveillance study to evaluate the tolerability of Rebif® New Formulation in patients with relapsing multiple sclerosis in an Australian clinical setting. (ReNew)

9th August, 2011

Type of MS: relapsing-remitting

Read More

The efficacy of botulinum toxin in disabling multiple sclerosis (MS) tremor

9th August, 2011

Type of MS: relapsing-remitting, secondary progressive

Read More

Showing 1 to 10 of 13